- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1449
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1,449 companies
Neurocrine Biosciences
Market Cap: US$9.5b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$90.72
7D
-11.8%
1Y
-33.3%
Viatris
Market Cap: US$9.3b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$7.26
7D
-11.0%
1Y
-37.3%
Innovent Biologics
Market Cap: HK$71.6b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$47.75
7D
-5.0%
1Y
27.8%
Medpace Holdings
Market Cap: US$9.2b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$282.33
7D
-7.2%
1Y
-29.8%
Qiagen
Market Cap: US$9.0b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$40.05
7D
-0.8%
1Y
-5.4%
Swedish Orphan Biovitrum
Market Cap: SEK 86.1b
An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 250.60
7D
-10.8%
1Y
-2.1%
Ipsen
Market Cap: €7.7b
Operates as a biopharmaceutical company worldwide.
IPN
€93.75
7D
-13.0%
1Y
-14.3%
Akeso
Market Cap: HK$66.6b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$82.20
7D
-4.3%
1Y
66.1%
Bio-Techne
Market Cap: US$8.5b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$49.26
7D
-10.2%
1Y
-28.4%
Exact Sciences
Market Cap: US$8.5b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$43.74
7D
-1.2%
1Y
-40.0%
Sino Biopharmaceutical
Market Cap: HK$61.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$3.58
7D
-8.0%
1Y
31.1%
CSPC Innovation Pharmaceutical
Market Cap: CN¥57.7b
Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.
300765
CN¥41.51
7D
6.2%
1Y
33.8%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥57.4b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.84
7D
-6.5%
1Y
5.7%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥57.3b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥44.13
7D
-1.0%
1Y
4.9%
Bio-Rad Laboratories
Market Cap: US$7.8b
Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
BIO
US$232.29
7D
-1.0%
1Y
-25.5%
Corcept Therapeutics
Market Cap: US$7.7b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$67.73
7D
-14.7%
1Y
184.3%
Chongqing Zhifei Biological Products
Market Cap: CN¥56.0b
Chongqing Zhifei Biological Products Co., Ltd.
300122
CN¥23.01
7D
-8.7%
1Y
-43.8%
Imeik Technology DevelopmentLtd
Market Cap: CN¥56.0b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥183.08
7D
1.1%
1Y
-11.6%
CSPC Pharmaceutical Group
Market Cap: HK$59.2b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093
HK$5.27
7D
-4.7%
1Y
-11.3%
Kyowa Kirin
Market Cap: JP¥1.1t
Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.
4151
JP¥2,121.00
7D
0.07%
1Y
-19.8%
Orion Oyj
Market Cap: €6.8b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€48.50
7D
-12.5%
1Y
46.2%
Sichuan Kelun Pharmaceutical
Market Cap: CN¥54.8b
Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.
002422
CN¥35.68
7D
-3.1%
1Y
19.9%
Halozyme Therapeutics
Market Cap: US$7.5b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$57.70
7D
-6.8%
1Y
46.7%
Eisai
Market Cap: JP¥1.0t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥3,716.00
7D
-4.8%
1Y
-37.7%
Aurobindo Pharma
Market Cap: ₹614.5b
A biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.
AUROPHARMA
₹1,082.45
7D
-2.1%
1Y
-0.6%
Roivant Sciences
Market Cap: US$7.1b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.
ROIV
US$9.65
7D
-3.6%
1Y
-13.6%
Repligen
Market Cap: US$7.0b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$115.19
7D
-5.3%
1Y
-34.6%
Madrigal Pharmaceuticals
Market Cap: US$6.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$307.35
7D
-6.0%
1Y
25.3%
Charles River Laboratories International
Market Cap: US$6.8b
Charles River Laboratories International, Inc.
CRL
US$99.95
7D
-29.1%
1Y
-59.4%
Alkem Laboratories
Market Cap: ₹578.6b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹4,887.45
7D
1.2%
1Y
3.2%
Jazz Pharmaceuticals
Market Cap: US$6.7b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$102.05
7D
-15.5%
1Y
-10.1%
Revolution Medicines
Market Cap: US$6.5b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$33.67
7D
2.4%
1Y
-10.0%
Bruker
Market Cap: US$6.2b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$38.07
7D
1.1%
1Y
-57.8%
Shanghai RAAS Blood Products
Market Cap: CN¥45.5b
Engages in the manufacture and sale of blood products in China.
002252
CN¥6.87
7D
-3.0%
1Y
1.5%
Beijing Tiantan Biological Products
Market Cap: CN¥44.8b
Beijing Tiantan Biological Products Co., Ltd.
600161
CN¥22.47
7D
8.6%
1Y
-1.6%
Legend Biotech
Market Cap: US$5.9b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$31.28
7D
-4.9%
1Y
-43.1%